NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B

A Pipeline Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Potential Contract ()
Duration
1 year
Value
£45M
Sector
HEALTH
Published
21 Oct 2021
Delivery
01 Mar 2022 to 28 Feb 2023
Deadline
n/a

Concepts

Location

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

Recombinant Factor IX

Total Quantity or Scope

YEAR: 2021/2022; BUDGET: 3,750,000.00 YEAR: 2022/2023; BUDGET: 41,250,000.00

CPV Codes

  • 33141530 - Blood coagulants

Indicators

  • Contract is suitable for SMEs.

Reference

Domains